Janice Bacon, MD
Obstetrics & Gynecology · West Columbia, SCNPI 1194789735
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,105 of the $8,596 with a category attached, or 82.7%. American Regent accounts for 83.1% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $7,513 and has fallen 99.5% since, to $35 in 2025. Among obstetrics & gynecology clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 57 payments — averaging $150.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- American Regent$7K
- Astellas Pharma US Inc$254
- AbbVie$170
- Therapeuticsmd, Inc.$145
- Pfizer$131
- Gilead$124
- plus $632 from 18 others
What the payments were for
- Consulting fees$7,10583%
- Food & beverage$1,28615%
- Education$2042%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| American Regent | 3 | $7,140 |
| Astellas Pharma US Inc | 6 | $254 |
| AbbVie | 6 | $170 |
| Therapeuticsmd, Inc. | 4 | $145 |
| Pfizer | 7 | $131 |
| Gilead | 1 | $124 |
| Daiichi Sankyo Inc. | 5 | $104 |
| Covidien LP | 1 | $72 |
| Exeltis, USA Inc. | 3 | $51 |
| Applied Medical Resources Corporation | 1 | $49 |
| Medtronic | 1 | $47 |
| Bayer | 3 | $44 |
| Meditrina | 2 | $38 |
| Shield Therapeutics Inc | 2 | $36 |
| Exact Sciences | 2 | $35 |
| AMAG Pharmaceuticals, Inc. | 2 | $25 |
| Kerecis Limited | 1 | $21 |
| Aspira Women's Health Inc | 1 | $20 |
| Agile Therapeutics, Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Avanos Medical | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Merck | 1 | $13 |
| Organon | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INJECTAFER$7,105
- Truvada$124
- IMVEXXY$107
How this compares
$8,596 in reported general payments places this provider in the 95th percentile of 673 obstetrics & gynecology providers in South Carolina.
See all obstetrics & gynecology providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 16 | $7,172 |
| Estradiol | 118 | $6,214 |
| Estradiol (Twice Weekly)Estradiol | 35 | $2,636 |
| ProgesteroneProgesterone, Micronized | 56 | $1,670 |
| Clobetasol Propionate | 25 | $822 |
| Acyclovir | 15 | $537 |
| SprintecNorgestimate-Ethinyl Estradiol | 13 | $271 |
| Medroxyprogesterone Acetate | 23 | $214 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 11 | $188 |
| Fluconazole | 13 | $80 |
| Alprazolam | 12 | $21 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $254 | $7,17216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 673 obstetrics & gynecology providers in South Carolina.
Other obstetrics & gynecology in West Columbia
- Brooke NaffzigerWest Columbia$70K
- Christopher HutchinsonWest Columbia$7K
- Alvin StrasburgerWest Columbia$7K
- Christopher JenningsAnderson$1.3M
- William ColemanGreenville$242K
- Melvin SeidMauldin$235K
- Judith BurgisColumbia$59K
- Charis ChambersGreenville$46K
- Angela ChoiCharleston$43K
- Andrew FuttermanCharleston$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.